Jeffrey M. Lemons

Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors

Jason J. Luke, Jeffrey M. Lemons, Theodore Karrison et al. · Journal of Clinical Oncology · 2018 · 587 citations

Medicine, Oncology, Radiation Oncology +17

Phase 1 Randomized Trial of Stereotactic Body Radiation Therapy Followed by Nivolumab plus Ipilimumab or Nivolumab Alone in Advanced/Unresectable Hepatocellular Carcinoma

Aditya Juloori, Rohan Katipally, Jeffrey M. Lemons et al. · International Journal of Radiation Oncology*Biology*Physics · 2022 · 86 citations

Medicine, Oncology, Radiation Oncology +17

Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I Trial

Jason J. Luke, Benjamin E. Onderdonk, Sandeep R. Bhave et al. · Clinical Cancer Research · 2020 · 71 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Prospective Cohort Study to Compare Long-Term Lung Cancer-Specific and All-Cause Survival of Clinical Early Stage (T1a–b; ≤20 mm) NSCLC Treated by Stereotactic Body Radiation Therapy and Surgery

Claudia I. Henschke, Rowena Yip, Qi Sun et al. · Journal of Thoracic Oncology · 2023 · 31 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Anatomical contouring variability in thoracic organs at risk

Ross McCall, Matthew Taylor, Nishele Lenards et al. · Medical dosimetry · 2016 · 17 citations

Medicine, Anatomy, Clinical Anatomy +11